Novartis AG vs Quantumscape Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Quantumscape Corp trades at $6.07 (market cap $3.62B). The key difference: Novartis AG is far larger — about 80.2× Quantumscape Corp's market cap, and Novartis AG pays a 3.17% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals.
| NVS | QS | |
|---|---|---|
Market Cap | $290.25B | $3.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $18.44 |
52-Week Low | $113.50 | $5.86 |
Enterprise Value | $330.27B | $2.79B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →